HIGH-TECH MEDICAL CARE AS A FACTOR IN THE DEVELOPMENT OF UROLOGY IN THE MOSCOW REGION

by P. A. Scheplev, V. V. Hvorov
Published 2018-05-01

FROM EDITION

by P. A. Scheplev
Published 2018-05-01

Artificial intelligence in medicine: from hybrid studies and clinical validation to development of application models

by O. B. Zhukov, P. A. Scheplev, A. V. Ignatiev
Published 2019-10-01

Efficacy and safety of a combined use of alpha1-blocker doxazosin and phosphodiesterase-5 inhibitor udenafil in patients with benign prostatic hyperplasia

by S. K. Martazinova, P. A. Scheplev
Published 2014-11-01

STRICTURE OF THE URETHRA AS A DISEASE OF THE URINARY CANAL AND PROMISING METHODS OF URETHRAL RECONSTRUCTIVE SURGERY (TISSUE ENGINEERING, BIOMATERIALS). Part 1

by V. V. Ipatenkov, N. P. Naumov, P. A. Scheplev, D. I. Naumova
Published 2018-05-01

EFFECTIVENESS AND SAFETY OF THE «DE ALEX» BIO COMPLEX AS MONOTHERAPY AND IN COMBINATION WITH TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

by P. A. Scheplev, V. V. Ipatenkov, N. P. Naumov
Published 2017-11-01

The role of antioxidants in prevention of male infertility

by N. P. Naumov, P. A. Scheplev, V. V. Polozov
Published 2019-04-01

Our andrology, or How did the ugly duckling turn into a white swan

by P. A. Scheplev
Published 2018-12-01

Efficacy and safety of a combined use of alpha1-blocker doxazosin and phosphodiesterase-5 inhibitor udenafil in patients with benign prostatic hyperplasia

by S. K. Martazinova, P. A. Scheplev
Published 2014-11-01